DNA Evidence Credential Authority Failure Through Defective Test Kit Validation Condition Undetected for Eight Months at Los Angeles County Sheriff's Department Scientific Services Bureau

Forensic DNA analysis in criminal proceedings depends on an accredited laboratory using validated instruments under controlled conditions. The DNA test result is the credential: it certifies that a biological sample was processed using a kit whose performance characteristics have been validated, that the resulting profile is a reliable representation of the sample, and that the analysis meets the quality standards under which the result is admissible as evidence. The validation condition is not an abstraction — it is the evidentiary basis for everything the result certifies. A result produced by a kit whose performance has been revoked by its manufacturer is a credential whose foundational condition was not present at generation.

The Los Angeles County Sheriff's Department Scientific Services Bureau is an accredited forensic laboratory that provides DNA analysis for LASD investigations and those of multiple other law enforcement agencies across Los Angeles County. The bureau uses standardized DNA test kits as part of its analytical workflow. In August 2024, the manufacturer of a specific lot of kits in use at the bureau notified the department that the kits were prone to intermittent poor performance that could cause incomplete or suboptimal results. The manufacturer recommended discontinuing use and offered free replacement kits. The notification was routed to an individual in the Scientific Services Bureau who was no longer employed by the department. No action was taken. The kits remained in use.

On March 24, 2025 — approximately seven months after the manufacturer's notification — a supervisor in the Scientific Services Bureau became aware of the August 2024 letter. The department publicly disclosed the issue two days later and announced that approximately 4,000 samples analyzed between July 2024 and February 2025 would require retesting. The disclosure triggered a response from the Los Angeles County District Attorney's Office, which announced it was working with the sheriff's department to identify affected cases and notify defense counsel where DNA material existed for retesting.

The eight-month gap between the manufacturer's notification and the department's discovery of it is the structural record of the credential gap. During that period, DNA results produced by kits whose performance validation had been revoked by the manufacturer were introduced in criminal proceedings as certified analytical results. The credential moved as sufficient. The cases affected — number still being determined at publication — include investigations where the DNA result was potentially the basis for charging decisions, plea negotiations, or trial evidence.

The DNA test result credential certifies that the kit used to produce it was performing within validated parameters at the point of analysis. That condition — current, confirmed kit performance validation — is the evidentiary boundary the credential is supposed to represent. When the manufacturer revoked that validation in August 2024, the condition the credential requires was no longer present. The results produced after that date carried the same documentary form as results produced before it. Courts, prosecutors, and defense counsel receiving those results had no mechanism to evaluate whether the kit performance condition the credential requires was present at the point of analysis. The credential moved as sufficient. The condition it was supposed to represent was not.

The routing of the manufacturer's notification to a former employee is the proximate cause of the eight-month gap. But the structural condition is deeper: the DNA result credential does not encode the kit performance validation status at the time of analysis. It certifies that the analysis was conducted by an accredited laboratory using standard procedures. It does not encode whether the specific kit used in the specific analysis was performing within validated parameters at that moment. The accreditation is the credential. The kit performance condition is assumed to persist from the original validation. When that assumption was revoked by the manufacturer, the credential did not change. It continued to move as sufficient.

The LASD launched an internal administrative investigation and committed to retesting approximately 4,000 samples. The Los Angeles County District Attorney's Office announced it would work with the sheriff's department to identify affected cases, notify defense counsel in appropriate cases, and retest where material remained available. The department acknowledged that some samples could not be retested due to limited sample size — a permanent consequence of the eight-month gap.

The manufacturer's characterization — that the defective kits were likely to produce incomplete rather than false results — limits but does not eliminate the evidentiary consequence. An incomplete DNA result that fails to produce a usable profile is a credential that cannot support its own claim. Cases where the result was relied upon to exclude a suspect, confirm an identification, or establish presence at a scene carry the same credential gap regardless of whether the defect produced a false positive or a degraded result. The retesting program addresses the gap prospectively. It does not resolve the cases already adjudicated on results produced during the eight-month window.

• The DNA test result credential certifies that a biological sample was analyzed using a validated, properly performing kit under defined laboratory conditions; the kit performance validation condition is the evidentiary boundary the credential is required to represent at the point of analysis; that condition was revoked by the manufacturer in August 2024 and was not present during eight months of continued kit use
• The manufacturer's August 28, 2024 notification was routed to a former employee of the Scientific Services Bureau and not acted upon; the kits remained in use from July 2024 through February 2025; the credential gap between the revocation of the kit performance validation and the department's awareness of it was produced by a notification routing failure — the validation condition was revoked; the credential continued to certify that it was present
• Approximately 4,000 samples were analyzed using kits whose performance validation had been revoked; results produced during that period moved through criminal proceedings as certified analytical results; courts, prosecutors, and defense counsel had no mechanism to evaluate whether the kit performance condition the credential requires was present at the point of analysis
• The DNA result credential does not encode the kit performance validation status at the point of analysis — it certifies accredited laboratory procedures and standard methodology; whether the specific kit used in a specific analysis was performing within manufacturer-validated parameters at that moment is not encoded in the credential and is not evaluable from the credential at the point of reliance
• Some samples cannot be retested due to limited sample size — a permanent consequence of the eight-month gap; cases adjudicated on results produced during the window carry credential gaps that retesting cannot resolve where material no longer exists; the remediation addresses future analysis; it does not restore the evidentiary boundary of results already relied upon
• The structural condition this case documents is distinct from laboratory fabrication or analyst misconduct — the analysts performed the analysis correctly under the procedures as they understood them; the credential gap was in the kit performance condition, not in the analytical process; a credential encoding the kit validation status at the point of analysis would have made the gap visible at the moment results were generated, not seven months later